贵阳白癜风治疗目前效果更好的医院贵阳哪家医院白癜风更好啊,贵阳白癜风医院哪家更好啊,贵阳白癜风医院在那里啊,贵阳白癜风的治疗,贵阳哪家白癜风治疗更好,贵阳白癜风什么医院好,贵阳白癜风治疗哪个医院更专业专科

Watching your dog get old is hard. You see the pain in their eyes when they can't get into the car or run after the ball.Veterinarians across the U.S. say it's not just old age, but arthritis that's causing your dog pain, and a new drug trial is working to make your furry companion feel better.One of the clinics testing the new drug is Paradise Animal Hospital in Catonsville, Maryland. Dr. Cheryl Burke says she to qualify for the trial, dogs have to have obvious signs of arthritis and cannot have cancer. At the clinic, they conduct blood tests, x-rays and a physical exam.Hannah, a blonde chow mix, came in for the procedure."She has a lot of trouble getting up and when she goes to walk up and down the stairs, she stares, like can I do this? Can I do this? Breaks my heart when I see that," Hannah's mom, Donna Foster said.Foster found out from a friend this clinic was conducting the trial and thought she'd take a chance, "I mean she's fourteen years old and basically she's really healthy so if I can keep her for another 20 years, I know that's not realistic but I will and I want her to have a quality of life."The trial was created in San Diego, by Animal Cell Therapies, and uses canine stem cells to grow cartilage in the joint, so the dog has more cushion when he/she walks or runs."Stem cells are the body's primitive precursor cells and we all have them, and when we're born, there's a huge population of them in our umbilical cord," Dr. Burke said.The stem cells adapt to the needs around them, so they could turn cancerous, something Dr. Burke and pet parents don't want. That's why dogs go through several tests (for free) before they can qualify.The clinic is doing the entire trial for free, to get FDA approval, so other pet parents can one day buy the drug.Part of the study requires that the test be double blind, meaning no one, even Dr. Burke can see which drug is given to the dog.Each dog undergoes the same procedure. Then pet parents come back for a one month, three month and six month check up to see how the dog is progressing.If the study is approved any dog who didn't get the drug will get it for free."If it's approved, it could be a few years, before it's on the market but it could be wonderful," Dr. Burke said.There is no ballpark figure as to how much the drug may cost, but dog lovers are hopeful it could help their furry friend have a longer, better life. 2431

WASHINGTON, D.C. – President Donald Trump's re-election campaign has scrapped plans to hold a rally in Alabama next weekend, CNN and The New York Post have confirmed.The cancellation of the event comes amid concerns about the rising number of coronavirus cases in parts of the United States, including the South.The campaign never formally announced the plans for the Alabama rally, but Trump was slated to travel to the state ahead of the GOP’s Senate primary race between his former attorney general, Jeff Sessions, and former Auburn University football coach, Tommy Tuberville.Campaign officials ultimately decided against it as state officials voiced concerns about a mass gathering during the COVID-19 pandemic, CNN reports.A person close the Trump campaign told CNN there are currently no rallies on the horizon, but aides are scoping out possible venues for future events.The canceled plans come as Trump continues to complain about the low turnout during his first return to the campaign trail in Tulsa, Oklahoma. 1029

WASHINGTON (AP) — Responding to an outcry from medical experts, Food and Drug Administration Commissioner Stephen Hahn on Tuesday apologized for overstating the life-saving benefits of treating COVID-19 patients with convalescent plasma.Scientists and medical experts have been pushing back against the claims about the treatment since President Donald Trump’s announcement on Sunday that the FDA had decided to issue emergency authorization for convalescent plasma, taken from patients who have recovered from the coronavirus and rich in antibodies.Trump hailed the decision as a historic breakthrough even though the treatment’s value has not been established.Hahn had echoed Trump in saying that 35 more people out of 100 would survive the coronavirus if they were treated with the plasma. That claim vastly overstated preliminary findings of Mayo Clinic observation. 878

Washington, D.C. (KGTV) - A bombshell surprise in the form of a mystery allegation led to the postponement for Darrell Issa's confirmation to serve in the Trump administration. The unusual machinations at Thursday's hearing in the Senate could derail the nomination and push Issa to run for Congress, instead.The scheduled hearing came one year to the day after President Donald Trump nominated Issa, a former nine-term congressman serving parts of San Diego and Orange County, to run the U.S. Trade and Development Agency. But as the hearing began, ranking Democrat Robert Menendez (D-New Jersey) moved that the hearing be held in private. "There's information in his FBI background investigation that concerns me greatly, and that I believe members may find problematic, and potentially disqualifying for Senate confirmation," Menendez said. "I firmly believe that every member of this committee should have the opportunity to review that information." He went on to suggest that holding the hearing in public could bring embarrassment or harm to Issa.Chairman James Risch (R-Idaho) initially suggested continuing in public, but then left the room for a brief conference with Menendez and Issa. When the senators returned, Issa was not with them. Risch revealed his decision to postpone the confirmation hearing indefinitely. Risch later told reporters he had seen nothing in Issa's FBI file that he found disqualifying.Afterward, in an interview with CNN, Issa suggested that Menendez was simply trying to defeat his nomination out of politics and that there is nothing in the background check that hasn't been previously reported in the media. "Senator Menendez has only brought up — and perhaps it's anecdotal but it's what he chose to bring up — my being disciplined for false ID when I was 17," Issa said."I was a Boy Scout, but I wasn't the perfect Boy Scout, so to speak, as a young man," Issa added. "I've dealt with that for 20 years in public life."Previously reported brushes with trouble when Issa was young include a guilty plea to carrying a concealed weapon, an arrest for car theft (the charge was later dropped) and a poor record for his service in the Army.Issa has reportedly said that if he is not confirmed soon, he will run for a return to Congress, challenging fellow Republican in the 50th District. While Issa has launched an exploratory committee, he told the Los Angeles Times Thursday he needs more time before making an official decision. 2477

Wednesday is the second and last day of Amazon’s Prime Day sales event.Though, it's not the only retailer trying to get your business this time of year. Target also started its own deal days Tuesday. And Walmart actually got a head start and started offering deals on Sunday.Popcart is a browser extension that helps you compare prices online. They say you might want to walk away from deals on last year's electronics.“Those may appear to be amazing deals because of the markdown, and that’s an interesting point about shopping online that what seems to be a very good deal, because you see 50% off, may not actually be the best deal you can get,” said Omri Traub, founder and CEO of Popcart.This week isn't your only chance to score savings.“Amazon and those biggest retailers want to spread out your shopping over a longer time period, because they’re going to face incredible pressure to deliver everything on time, to deliver many more items than they have in previous years,” said Traub.The competitive prices Walmart and Target offer this week may be foreshadowing what's to come on Black Friday. 1111